Source: JAMA Oncology. Unidade: FMRP
Subjects: NEOPLASIAS OVARIANAS, CITOTOXICIDADE IMUNOLÓGICA
ABNT
GOODE, Ellen L. et al. Dose-response association of CD8+ tumor-infiltrating lymphocytes and survival time in high-grade serous ovarian cancer. JAMA Oncology, v. 3, n. 12, 2017Tradução . . Disponível em: https://doi.org/10.1001/jamaoncol.2017.3290. Acesso em: 03 out. 2024.APA
Goode, E. L., Sousa, C. B. de, Tiezzi, D. G., Andrade, J. M. de, & Reis, F. J. C. dos. (2017). Dose-response association of CD8+ tumor-infiltrating lymphocytes and survival time in high-grade serous ovarian cancer. JAMA Oncology, 3( 12). doi:10.1001/jamaoncol.2017.3290NLM
Goode EL, Sousa CB de, Tiezzi DG, Andrade JM de, Reis FJC dos. Dose-response association of CD8+ tumor-infiltrating lymphocytes and survival time in high-grade serous ovarian cancer [Internet]. JAMA Oncology. 2017 ; 3( 12):[citado 2024 out. 03 ] Available from: https://doi.org/10.1001/jamaoncol.2017.3290Vancouver
Goode EL, Sousa CB de, Tiezzi DG, Andrade JM de, Reis FJC dos. Dose-response association of CD8+ tumor-infiltrating lymphocytes and survival time in high-grade serous ovarian cancer [Internet]. JAMA Oncology. 2017 ; 3( 12):[citado 2024 out. 03 ] Available from: https://doi.org/10.1001/jamaoncol.2017.3290